US-based Sight Sciences has published the two-year post-surgical outcomes of its minimally invasive glaucoma surgery device, the OMNI surgical system.
The data from the real-world clinical outcomes study was published in the American Journal of Ophthalmology. The study collected data for 77,391 patients with open-angle glaucoma who either received cataract surgery or a combination of cataract surgery and intervention with either of the three US FDA minimally invasive glaucoma surgery devices.
